Donald C. Porter
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$1.1MFederal grants as PI4 awards
1Patents grantedLatest Aug 9, 2016
27Papers1,281 citations
Federal awards and patents by year
AwardsPatents
4 awards · $1.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 24, 2017 | NIH | SBIR Phase I Targeting CDK8 for the treatment of vein graft failure | $299K | SENEX BIOTECHNOLOGY, INC. |
| Jun 28, 2017 | NIH | SBIR Phase I CDK8/19 inhibitor for the treatment of HER2+ breast cancer | $300K | SENEX BIOTECHNOLOGY, INC. |
| Dec 29, 2016 | NIH | SBIR Phase I Enhancing cytarabine efficacy in leukemia through CDK8/19 inhibition | $300K | SENEX BIOTECHNOLOGY, INC. |
| Sep 23, 2015 | NIH | SBIR Phase I CDK8/19 inhibitors for therapy of advanced prostate cancer | $241K | SENEX BIOTECHNOLOGY, INC. |
2 patents as inventor
- US 9409873SENEX BIOTECHNOLOGY, INC.Aug 9, 2016
- US SENEX BIOTECHNOLOGY, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,638
Awards as PI#566
Patents#155
Companies
- SENEX BIOTECHNOLOGY, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.